Spots Global Cancer Trial Database for recurrent nasopharyngeal cancer
Every month we try and update this database with for recurrent nasopharyngeal cancer cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| T-Lymphocytes in Treating Patients With Epstein-Barr Virus-Positive Nasopharyngeal Cancer, NPC | NCT00609219 | Head and Neck C... | autologous EBV ... | - | Baylor College of Medicine | |
| Carboplatin and Paclitaxel in Treating Patients With Locally Recurrent or Metastatic Nasopharyngeal Cancer | NCT00003206 | Head and Neck C... | carboplatin paclitaxel | 18 Years - 120 Years | Eastern Cooperative Oncology Group | |
| Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Advanced and/or Recurrent Head and Neck Cancer | NCT00004097 | Head and Neck C... | fluorouracil gemcitabine hyd... paclitaxel radiation thera... | 18 Years - | National Cancer Institute (NCI) | |
| EF5 Prior to Surgery or Biopsy in Patients With Breast, Prostate, or Cervical Cancer or High Grade Soft Tissue Sarcoma | NCT00004261 | Breast Cancer Cervical Cancer Head and Neck C... Prostate Cancer Sarcoma | EF5 flow cytometry fluorescent ant... immunohistochem... biopsy | 18 Years - 120 Years | University Health Network, Toronto | |
| Carboplatin and Paclitaxel in Treating Patients With Locally Recurrent or Metastatic Nasopharyngeal Cancer | NCT00003206 | Head and Neck C... | carboplatin paclitaxel | 18 Years - 120 Years | Eastern Cooperative Oncology Group | |
| Amifostine Plus Chemotherapy and Radiation Therapy in Treating Patients With Advanced, Unresectable Head and Neck Cancer | NCT00003251 | Drug/Agent Toxi... Head and Neck C... Radiation Toxic... | amifostine trih... cisplatin paclitaxel radiation thera... | 18 Years - | National Cancer Institute (NCI) | |
| Paclitaxel in Treating Patients With Recurrent or Refractory Head and Neck Cancer | NCT00003327 | Head and Neck C... | paclitaxel | 18 Years - | National Cancer Institute (NCI) | |
| L-778,123 in Treating Patients With Recurrent or Refractory Solid Tumors | NCT00003430 | Head and Neck C... Unspecified Adu... | L-778,123 | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Sargramostim in Decreasing Mucositis in Patients Receiving Radiation Therapy for Head and Neck Cancer | NCT00008398 | Head and Neck C... Oral Complicati... Radiation Toxic... | sargramostim quality-of-life... radiation thera... | - | Radiation Therapy Oncology Group | |
| 18F-FPPRGD2 PET/CT or PET/MRI in Predicting Early Response in Patients With Cancer Receiving Anti-Angiogenesis Therapy | NCT01806675 | Adult Giant Cel... Adult Glioblast... Adult Gliosarco... Male Breast Can... Metastatic Squa... Recurrent Adeno... Recurrent Adult... Recurrent Basal... Recurrent Colon... Recurrent Esthe... Recurrent Hypop... Recurrent Inver... Recurrent Laryn... Recurrent Lip a... Recurrent Lymph... Recurrent Lymph... Recurrent Metas... Recurrent Midli... Recurrent Mucoe... Recurrent Nasop... Recurrent Non-s... Recurrent Oroph... Recurrent Pancr... Recurrent Paran... Recurrent Recta... Recurrent Renal... Recurrent Saliv... Stage IIIA Brea... Stage IIIA Non-... Stage IIIB Brea... Stage IIIB Non-... Stage IIIC Brea... Stage IV Breast... Stage IV Non-sm... Stage IV Pancre... Stage IV Renal ... Stage IVA Colon... Stage IVA Recta... Stage IVA Saliv... Stage IVB Colon... Stage IVB Saliv... Stage IVC Saliv... Tongue Cancer Unspecified Adu... | 18F-fludeoxyglu... 18F-FPPRGD2 | 18 Years - | Stanford University | |
| EF5 Prior to Surgery or Biopsy in Patients With Breast, Prostate, or Cervical Cancer or High Grade Soft Tissue Sarcoma | NCT00004261 | Breast Cancer Cervical Cancer Head and Neck C... Prostate Cancer Sarcoma | EF5 flow cytometry fluorescent ant... immunohistochem... biopsy | 18 Years - 120 Years | University Health Network, Toronto | |
| L-778,123 in Treating Patients With Recurrent or Refractory Solid Tumors | NCT00003430 | Head and Neck C... Unspecified Adu... | L-778,123 | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Bortezomib and Gemcitabine in Treating Patients With Recurrent or Metastatic Nasopharyngeal Cancer | NCT00305734 | Recurrent Nasop... Stage IV Nasoph... | bortezomib gemcitabine hyd... laboratory biom... | 18 Years - | National Cancer Institute (NCI) | |
| Cisplatin and Gemcitabine in Treating Patients With Advanced Squamous Cell Cancer of the Head and Neck | NCT00003182 | Head and Neck C... | cisplatin gemcitabine hyd... | 18 Years - | National Cancer Institute (NCI) | |
| Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced or Refractory Solid Tumors | NCT00499291 | Cancer | paclitaxel albu... gene expression... laboratory biom... pharmacological... polymerase chai... | 18 Years - 120 Years | Eastern Cooperative Oncology Group |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
